We are live on ! Find out more
GA

General Atlantic Portfolio holdings

AUM $2.15B
1-Year Est. Return 35.02%
This Fund
S&P 500
This Quarter Est. Return
+10.97%
1 Year Est. Return
+35.02%
3 Year Est. Return
+185.68%
5 Year Est. Return
+122.28%
10 Year Est. Return
+1,080.07%
AUM
$6.34B
AUM Growth
-$2.26B
Cap. Flow
-$2.41B
Cap. Flow %
-38.05%
Top 10 Hldgs %
86.83%
Holding
33
New
2
Increased
4
Reduced
2
Closed
3

Top Buys

Rank Stock Value
1
AKRO
Akero Therapeutics
AKRO
+$81.8M
2
XP icon
XP
XP
+$73M
3
SLRN
ACELYRIN
SLRN
+$30.7M
4
DLO icon
dLocal
DLO
+$28.6M
5
PHVS icon
Pharvaris
PHVS
+$19.2M

Sector Composition

Rank Sector Weight
1 Technology 59.18%
2 Healthcare 15.37%
3 Financials 11.65%
4 Industrials 5.72%
5 Consumer Staples 4.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THRD
26
DELISTED
Third Harmonic Bio
THRD
$14.2M 0.22%
2,958,762
LOGC
27
DELISTED
ContextLogic
LOGC
$4.01M 0.06%
609,615
-1
-0% -$8
BZFD icon
28
BuzzFeed
BZFD
$102M
$3.97M 0.06%
1,965,626
GROV icon
29
Grove Collaborative
GROV
$45M
$1.66M 0.03%
936,020
ADAG
30
Adagene
ADAG
$250M
$391K 0.01%
264,000
IOT icon
31
Samsara
IOT
$23.1B
-9,227,020
Closed -$182M
OSH
32
DELISTED
Oak Street Health, Inc.
OSH
-61,384,475
Closed -$2.37B
CIH
33
DELISTED
China Index Holdings Limited American Depository Shares
CIH
-10,122,769
Closed -$9.54M

Similar funds

General Atlantic's Q2 2023 Portfolio in Review

As of Q2 2023, General Atlantic held 33 positions worth $6.34B, down 26% from $8.61B the previous quarter. Its ten largest holdings account for 87% of the portfolio.

General Atlantic withdrew a net $2.41B in Q2 2023, closing 3 positions and reducing 2 holdings. Its most notable exit was Oak Street Health, Inc., an estimated $2.37B position sold in full.

By sector, the portfolio is most concentrated in Technology at 59% of assets, up from 49% a quarter earlier, followed by Healthcare and Financials.

Against the trend, General Atlantic opened a new position in Akero Therapeutics worth $83.4M.

  • General Atlantic's largest Q2 2023 buy was Akero Therapeutics: 1,785,714 shares worth $83.4M.
  • General Atlantic added most to XP in Q2 2023, an estimated $73M increase.
  • General Atlantic's biggest Q2 2023 reduction was Duolingo, cutting an estimated $83.6M.
  • General Atlantic fully exited Oak Street Health, Inc. in Q2 2023, selling an estimated $2.37B.
  • General Atlantic's ten largest holdings make up 87% of its $6.34B portfolio in Q2 2023.
  • General Atlantic opened 2 new positions and closed 3 in Q2 2023.
  • General Atlantic's portfolio value fell 26% quarter-over-quarter to $6.34B.

Based on General Atlantic's 13F filing for Q2 2023, filed 11 Aug 2023.